Bing

SEARCH HISTORY

Earnings, however, missed expectations. Alexza Pharmaceuticals Inc. (ALXA) said it initiated a 10-for-1 reverse stock split of its outstanding shares in an effort to regain compliance with Nasdaq and stay listed on the exchange. Career Education Corp ...
The Wall Street Journal · ByMia Lamar · 6/13/2012
Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports and industry newsletters. Alexza Pharmaceuticals is focused on the research, development and commercialization of novel ...
marketwired.com · 1/22/2013
PH: GLG Life Tech needs to extend terms for much of its $100 million ($100M) in debt, which has been an overhang on the stock in recent years ... PH: Alexza Pharmaceuticals Inc. (ALXA) has resumed development for a Staccato-delivered formulation of ...
Equities · 6/10/2015
May 3, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA), or the Company ... in gross proceeds in a registered direct offering through the sale of common stock and warrants. The Company agreed to sell a total of 11,927,034 units, each ...
redOrbit · 5/3/2011
Alexza Pharmaceuticals (NASDAQ:ALXA) said Tuesday that the Psychopharmacologic Drugs ... agitation in patients with schizophrenia or bipolar mania. The news sent Alexza stock on the Nasdaq Exchange as high as $0.99 per share today. As of 1:09 …
Proactiveinvestors · 12/13/2011
Investors appeared to get worried after FDA staffers cited worries about lung safety issues with Alexza Pharmaceuticals' ($ALXA) inhaled anti-agitation drug Adasuve. Shares of the developers stock were down 47.47% yesterday, with the safety concerns ...
Fierce Biotech · ByRyan Mcbride · 12/9/2011
He also serves as a member of the board of directors of Stemline Therapeutics (NASDAQ: STML), Alexza Pharmaceuticals (NASDAQ: ALXA), and Benitec Biopharma (Australian Stock Exchange: BLT). Mr. Buchi graduated from Cornell University with a …
Business Wire · 6/27/2013
It generally represents the market's view of a company's stock value and is a determining factor in stock valuation. For example, if a company has 1.5 million shares outstanding at a share price of $25, its market cap is $37.5 million (1.5 million x $25).
YCharts · 7/15/2015
and BARCELONA, Spain, Oct. 27, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) and Grupo Ferrer Internacional ... that Ferrer will purchase 2 million shares of Alexza common stock for $4.00 per share, thereby becoming the …
The Wall Street Transcript · 10/27/2014
Mr. Turner currently serves on the Boards of Directors and is the chair of the audit committees of three publicly-traded pharmaceutical companies: Kythera Biopharmaceuticals (NASDAQ: KYTH), Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) and Corcept ...
CNW Group · 7/16/2013